COMMUNIQUÉS West-GlobeNewswire
-
Top Line Results from Glaucoma Dolomites Phase 2 Trial Show Nicox’s NCX 470 Meets Primary Endpoint and Demonstrates Statistical Superiority vs Latanoprost
02/10/2019 - 07:30 -
Nexstim Plc in Technology Licensing Discussions with a Leading California Based Academic Institution
02/10/2019 - 08:00 -
New Data Presented on ASLAN’s varlitinib at ESMO 2019
02/10/2019 - 08:30 -
AgraFlora Organics Reviews Delta Greenhouse Infrastructure Upgrades; Deploys Over C$30,000,000 in PPE Expenditures
02/10/2019 - 09:01 -
Demant A/S: Change of date of publication of Interim Management Statement
02/10/2019 - 09:53 -
RavenQuest BioMed to Hold Third Quarter Conference Call
01/10/2019 - 23:56 -
Jounce Therapeutics to Present Two Posters from the JTX-4014 and Vopratelimab Programs at the Society for Immunotherapy of Cancer’s (SITC) 34th Annual Meeting
02/10/2019 - 00:01 -
NextCure to Present Clinical Data from NC318 Phase 1/2 Clinical Trial at 34th Annual Meeting of SITC
02/10/2019 - 00:20 -
BriaCell Therapeutics Corp. to Clarify Record Date
02/10/2019 - 01:00 -
Information relative au nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2019
01/10/2019 - 18:00 -
Information on total number of voting rights and shares composing the share capital as at September 30, 2019
01/10/2019 - 18:00 -
SuperSonic Imagine Innovates in Ultrasound with Its New Liver Markers
01/10/2019 - 18:00 -
Virbac : Déclaration d'actions et de droits de vote 09/2019
01/10/2019 - 18:11 -
Virbac : Declaration of the number of shares and voting rights 09/2019
01/10/2019 - 18:11 -
Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday October 15, 2019 at 9:30 AM
01/10/2019 - 18:40 -
B. Braun Successfully Integrate Smart Pumps with STANLEY Healthcare at Saratoga Hospital
01/10/2019 - 19:48 -
Theratechnologies annoncera ses résultats du troisième trimestre de 2019
01/10/2019 - 20:14 -
Theratechnologies to Announce Financial Results for Third Quarter 2019
01/10/2019 - 20:14 -
Capital Increase in Genmab as a Result of Employee Warrant Exercise
01/10/2019 - 20:14
Pages